Protease-induced infectivity of hepatitis B virus for a human hepatoblastoma cell line

Journal of Virology

Volumn 70, Issue 4, 1996, Pages 2277-2285

  Lu, Xuanyong ^a,c   Block, Timothy M ^b   Gerlich, Wolfram H ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^c Department of Microbiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHYMOTRYPSIN; PROTEINASE;

ARTICLE; CANCER CELL CULTURE; ENZYME ANALYSIS; HEPATITIS B; HEPATITIS B VIRUS; HEPATOBLASTOMA; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; VIRION; VIRUS INFECTIVITY; VIRUS PATHOGENESIS;

EID: 0029887665     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.4.2277-2285.1996     Document Type: Article

References (52)

1. Acs, G., M. A. Sells, R. H. Purcell, P. Price, R. Engle, M. Shapiro, and H. Popper. 1987. Hepatitis B virus produced by transfected HepG2 cells causes hepatitis in chimpanzee. Proc. Natl. Acad. Sci. USA 84:4641-4644
2. Aldrich, C. E., L. Coates, T.-T. Wu, J. Newbold, B. C. Tennant, J. Summers, C. Seeger, and W. S. Mason. 1989. In vitro infection of woodchuck hepatocytes with woodchuck hepatitis virus and ground squirrel hepatitis virus. Virology 172:247-252.
3. Bchini, R., F. Capel, C. Dauguet, S. Dubanchet, and M. A. Petit. 1990. In vitro infection of human hepatoma (HepG2) cells with hepatitis B virus. J. Virol. 64:3025-3032.
4. Block, T., X. Lu, F. Platt, G. Foster, W. H. Gerlich, B. S. Blumberg, and R. Dwek. 1994. Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin. Proc. Natl. Acad. Sci. USA 91:2235-2239.
5. Brass. V., X. Lu, R. Thomssen, and W. H. Gerlich. 1994. Post-translational alterations in transmembrane topology of the hepatitis B virus large envelope protein. EMBO J. 13:2773-2779.
6. Budkottska, A., C. Juan, F. Groh, P. Bedossa, P. Dubreuil, J. P. Bouvet, and J. Pillot. 1993. Hepatitis B virus (HBV) binding factor in human serum. candidate for a soluble form of hepatocyte HBV receptors. J. Virol. 67:4316-4322.
7. Ellis, R. W. (ed.). 1993. Hepatitis B vaccines in clinical practice Marcel Dekker. Inc., New York
8. Galle, P. R., J. Hagelstein, B. Kommerell, M. Volkmann, P. Schranz, and H. Zentgraf. 1994. In vitro experimental infection of primary human hepatocytes with hepatitis B virus. Gastroenterology 106:664-673.
9. Gerlich, W. H. 1993. Viral hepatitis, p 83-113. In A. J. Zuckerman and H C. Thomas (ed), Biology of hepatitis B virus. Churchill Livingstone, Edinburgh
10. Gerlich, W. H., K.-H. Heermann, R. Thomssen, and the Eurohep Group. 1994 Quantitative assays for hepatitis B virus DNA: standardization and quality control. Viral Hepatitis Rev. 1:53-57.
11. Gerlich, W. H., X. Lu, and K. H. Heermann. 1993. Studies on the attachment and penetration of hepatitis B virus. J. Hepatol. 17(Suppl. 3):S10-S14.
12. Gripon, P., C. Diot, N. Theze, I. Fourel, O. Loreal, C. Brechot, and C. Guguen-Guillouzo. 1988. Hepatitis B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulfoxide. J. Virol. 62:4136-4143.
13. Gripon, P., C. Diot, and C. Guguen-Guillouzo. 1993. Reproducible high level infection of cultured adult human hepatocytes by hepatitis B virus: effect of polyethylene glycol on adsorption and penetration. Virology 192:534-540.
14. Heermann, K. H., U. Goldmann, W. Schwartz, T. Seyffarth, H. Baumgarten, and W. H. Gerlich. 1984. Large surface proteins of hepatitis B virus containing the pre-S sequence J Virol. 52:396-402.
15. Heermann, K. H., F. Kruse, M. Seifer, and W. H. Gerlieh. 1987. Immunogenicity of gene S and pre-S domains in hepatitis virions and HBsAg filaments Intervirology 28:14-25.
16. Heo, K. D. S., J.-G. Park, K. Hata, R. Day, R. B. Herberman, and T. L. Whiteside. 1990. Evaluation of tetrazolium based semiautomatic colorimetric assay for measurement of human antitumor cytotoxicity. Cancer Res. 50: 3681-3690.
17. 2 fragment of anti-human liver endonexin II immunoglobulin G: evidence for a receptor-ligand-like relationship between small hepatitis B surface antigen and endonexin II. J. Virol 68:1516-1521.
18. Höhne, M., S. Schaefer, M. Seifer, M. A. Feitelson, D. Paul, and W. H. Gerlieh. 1990 Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA EMBO J. 9:1137-1145.
19. Isreal, J., and W. T. London. 1990. Liver structure, function and anatomy effects of hepatitis B virus. Curr Top. Microbiol. Immunol. 168:1-20.
20. Köck, J., and H. J. Schlicht. 1993. Analysis of the earliest steps of hepadnavirus replication: genome repair after infectious entry into hepatocytes does not depend on viral polymerase activity J. Virol. 67:4867-4874.
21. Korec, E., and W. H. Gerlich. 1992. HBc and HBe specifity of monoclonal antibodies against complete and truncated HBc proteins from E. coli Arch. Virol. Suppl. 4:119-121.
22. Kiwalski, D., W. D. Kroeker, and M. Laskowski. 1976. Mungbean nuclease 1: physical, chemical and catalytic properties. Biochemistry 15:4457-4463.
23. Lobigs, M., and H. Garoff. 1990. Fusion function of Semliki Forest virus spike is activated by proteolytic cleavage of the envelope glycoprotein precursor P62. J. Virol. 64:1233-1240.
24. Lu, X., and W. H. Gerlich. Proteolysis-induced binding of a fusion peptide-like structure in hepatitis B surface antigen to cellular membranes Submitted for publication.
25. 24a. Lu, X., and W.-H. Gerlich. Unpublished data.
26. Lu, X., A. Mehta, R. Dwek, T. Butters, and T. Block. 1995. Evidence that N-linked glycosylation is necessary for hepatitis B virus secretion. Virology 213:550-665.
27. Marsh, M., and A. Helenius. 1989. Virus entry into animal cells. Adv. Virus Res. 36:107-151.
28. Mason, W. S., and C. Seeger. 1991. Hepadnaviruses - molecular biology and pathogenesis. Curr. Top. Microbiol. Immunol. 168.
29. McLachlan, A. 1991. Molecular biology of the hepatitis B virus. CRC Press, Inc., Boca Raton, Fla.
30. Meisel, H., I. Sominskaya, P. Pumpens, P. Pushko, G. Borisova, R. Deepen, X. Lu, G. H. Spiller, D. H., Krüger, E. Grens, and W. H. Gerlich. 1994. Fine mapping and functional characterization of two immunodominant regions from the preS2 sequence of hepatitis B virus Intervirology 37:330-339.
31. Morrison, T. G. 1988. Structure, function and intracellular processing of paramyxovirus membrane proteins. Virus Res. 10:113-136.
32. Nagai, Y. 1993 Protease-dependent virus tropism and pathogenicity. Trends Microbiol 1:81-87.
33. Neurath, A. R., S. B. H. Kent, N. Strick, and K. Parker. 1986 Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell 46:429-436.
34. Ochiya, K., T. Tsurimoto, K. Ueda, K. Okubo, M. Shiozawa, and K. Matsubara. 1989. An in vitro system for infection with hepatitis B virus that uses primary human fetal hepatocytes. Proc. Natl. Sci USA 86:1875-1879
35. Pontisso, P. M., M. G. Ruvoletto, W. H. Gerlich, K.-H. Heermann, R. Bardini, and A. Alberti. 1989. Identification of an attachment site for human liver plasma membranes on hepatitis B virus particles. Virology 173:522-530.
36. Possehl, C. 1993. Studies on structural proteins of hepatitis B virus. Ph.D. Thesis. University of Gottingen, Gottingen, Germany.
37. Possehl, C., R. Repp, K.-H. Heermann, E. Korec, A. Uy, and W. H. Gerlich. 1992 Absence of free core antigen in anti-HBc negative viremic hepatitis B carriers Arch. Virol. Suppl. 4:39-41
38. Qiao M., T. B. MacNaughton, and E. J. Gowans. 1994. Adsorption and penetration of hepatitis B virus in a nonpermissive cell line. Virology 201:356-363.
39. Rijintjes, P. J., H. J. Moshage, and S. H. Yap. 1988. In vitro infection of primary cultures of cryopreserved adult human hepatocytes with hepatitis B virus Virus Res. 10:95-110.
40. Roririguez-Crespo, I., E. Nunez, J. Gomez-Gutierrrez, B. Yelamos, J. P. Albar, D. L. Peterson, and F. Galvilanes. 1995. Phosplohpid interactions of the putative fusion peptide of hepatitis B virus surface antigen S protein. J. Gen. Virol. 76:301-305
41. Roingeard, P., X. Lu, C. Sureau, M. Freschlin, B. Arbeille, M. Essex, and J. L. Romet-Lemonne. 1990. Immunocytochemical and electron microscopic study of hepatitis B virus antigen and complete particle production in hepatitis B virus DNA transfected HepG2 cells. Hepatology 11:277-285.
42. Rott, R. 1992. The pathogenic determinant of influenza virus. Vet. Microbiol. 33:303-310.
43. Sells, M., M. Chen, and G. Acs. 1987. Production of hepatitis B virus in HepG2 cells transfected with clonal hepatitis B virus DNA. Proc. Natl Acad. Sci. USA 84:1005-1009.
44. Sells, M., A. Z. Zelent, M. Shvartsman, and G. Acs. 1988. Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions J. Virol. 62:2836-2844.
45. Stibbe, W., and W. H. Gerlich. 1983. Structural relationships between minor and major glycoproteins of hepatitis B surface antigen. J. Virol 46:626-628.
46. Sureau, C. 1993. In vitro culture systems for hepatitis B and delta viruses. Arch. Virol. Suppl. 8:3-14.
47. Theze, N., P. Gripon, I. Fourel, O. Hantz, C. Trepn, and C. Guguen-Guillouzo. 1987. Maintenance of woodchuck hepatitis virus activity in primary cultures of woodchuck hepatocytes J. Gen. Virol. 68:1029-1039.
48. Tuttleman, J. S., C. Pourcel, and J. W. Summers. 1986. Formation of the pool of covalenty closed circular viral DNA in hepadnavirus-infected cells. Cell 47:451-460.
49. Tuttleman, J. S., J. C. Pugh, and J. W. Summers. 1986. In vitro experimental infection of primary duck hepatocyte cultures with hepatitis B virus. J. Virol. 58:17-25.
50. White, J. M. 1992. Membrane fusion Science 258:917-924.
51. Winchester, B., and G. W. J. Fleet. 1992. Amino sugar glycosidase inhibitors: versatile tools for glycobiologists. Glycobiology 2:199-210.
52. Zuckerman, A. J., and H. C. Thomas. 1993. Viral hepatitis. Churchill Livingstone, Edinburgh.